Efficacy and Safety of Tasimelteon Compared With Placebo in Totally Blind Subjects With Non-24-Hour Sleep-Wake Disorder
Clinical trial NCT01163032 · COMPLETED
Trial details
- NCT number
- NCT01163032
- Sponsor
- Vanda Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2012-11-01
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.